ATAI ATAI Life Sciences BV

USD 1.97 0.18 10.055866
Icon

ATAI Life Sciences BV (ATAI) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 1.97

+0.18 (+10.06)%

USD 0.28B

2.96M

N/A

USD 15.00 (+661.42%)

Icon

ATAI

ATAI Life Sciences BV (USD)
COMMON STOCK | NSD
USD 1.97
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 0.28B

USD 15.00 (+661.42%)

USD 1.97

ATAI Life Sciences BV (ATAI) Stock Forecast

N/A

Based on the ATAI Life Sciences BV stock forecast from 0 analysts, the average analyst target price for ATAI Life Sciences BV is not available over the next 12 months. ATAI Life Sciences BV’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ATAI Life Sciences BV is Slightly Bullish , which is based on 5 positive signals and 4 negative signals. At the last closing, ATAI Life Sciences BV’s stock price was USD 1.97. ATAI Life Sciences BV’s stock price has changed by +17.96% over the past week, +0.51% over the past month and +48.12% over the last year.

No recent analyst target price found for ATAI Life Sciences BV
No recent average analyst rating found for ATAI Life Sciences BV

Company Overview ATAI Life Sciences BV

ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive n...Read More

https://www.atai.life

Krausenstrasse 9-10, Berlin, Germany, 10117

133

December

USD

USA

Adjusted Closing Price for ATAI Life Sciences BV (ATAI)

Loading...

Unadjusted Closing Price for ATAI Life Sciences BV (ATAI)

Loading...

Share Trading Volume for ATAI Life Sciences BV Shares

Loading...

Compare Performance of ATAI Life Sciences BV Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ATAI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To ATAI Life Sciences BV (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing ATAI

Symbol Name ATAI's Weight Expense Ratio Price(Change) Market Cap
PSIL
AdvisorShares Psychedelic.. 3.91 % 0.99 % 0.00 (0.00%) USD7.46M

Frequently Asked Questions About ATAI Life Sciences BV (ATAI) Stock

Stock Target Advisor's fundamental analysis for ATAI Life Sciences BV's stock is Slightly Bullish .

Unfortunately we do not have enough data on ATAI's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ATAI's stock to indicate what its average analyst target is.

ATAI stock's Price/Earning ratio is 0.30. Our analysis grades ATAI stock's Price / Earning ratio at B-. This means that ATAI stock's Price/Earning ratio is above 18.99999999999999% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ATAI may be undervalued for its sector.

The last closing price of ATAI's stock was USD 1.97.

The most recent market capitalization for ATAI is USD 0.28B.

Unfortunately we do not have enough analyst data on ATAI's stock to indicate whether its price will go up or not.

Following are ETFs with the highest allocation to ATAI Life Sciences BV's stock :

PSIL

As per our most recent records ATAI Life Sciences BV has 133 Employees.

ATAI Life Sciences BV's registered address is Krausenstrasse 9-10, Berlin, Germany, 10117. You can get more information about it from ATAI Life Sciences BV's website at https://www.atai.life.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...